Prolyl-Hydroxylase Inhibitor Stimulates EPO Production in Patients With ESRD - Medscape PDF Print
Medscape
"Our results confirm that both the liver and the kidneys retain a significant production capacity for erythropoietin in end-stage renal disease patients,"

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.